SINGAPORE (Reuters) - South Korea stole headlines after creating the world's first cloned dog, but the tiny city-state of Singapore is quietly preparing to take the fruits of its stem cell research straight to the market.
Steven Fang, chief executive of Singapore-based CyGenics, said more Singapore-based firms are taking the greenfield research of U.S. and Korean scientists and turning it into marketable technology safe for human use.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
